Latest Commercialization News

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

Volt Resources has reshaped its executive team to sharpen focus on downstream graphite refining and advanced materials, appointing Trevor Matthews to its board while repositioning CEO Prashant Chintawar.

HITIQ has secured a pivotal one-year deal with the South Metro Junior Football League, positioning its PROTEQT concussion management system at the heart of junior sports safety. This move complements existing partnerships and signals a strong push into Australia’s grassroots sports market.

DXN Limited has secured a significant A$4.6 million contract to deliver three modular data centre units to Globalstar, marking a strategic expansion into satellite communications infrastructure.

Clean TeQ Water reports a successful lithium extraction pilot and the amicable termination of its LithiumBank agreements, setting the stage for new global deployments of its cDLE® technology.

EV Resources Limited has agreed to sell its Yanamina Gold and Silver Project in Peru to Daura Gold Corp for US$6 million, a move that will bolster EVR’s cash reserves and sharpen its strategic focus.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.

Redivium Limited has secured a definitive five-year marketing and offtake agreement with WMC Energy BV, ensuring exclusive global sales of black mass from its UK battery recycling facility.

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.

Firetail Resources has secured exclusive options to acquire two promising gold projects in Nevada and South Dakota, expanding its footprint in premier North American gold districts.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.

Metal Powder Works has doubled its production capacity for advanced metal powders using its patented DirectPowder™ process, achieving this milestone without additional capital expenditure. The company also cut production cycle times by up to 40%, positioning itself as a key US supplier for defence applications.